Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy

Low dose thymoglobulin versus basiliximab in cytomegalovirus positive kidney transplant recipients: Effectiveness of preemptive cytomegalovirus modified strategy

Show other versions (1)

Background: We performed a retrospective trial to determine asymptomatic CMV reactivation and CMV disease in kidney allograft recipients with positive CMV serostatus. Methods: Preemptive modified strategy under low dose thymoglobulin versus basiliximab induction was evaluated. Patients were monitore...

Full description

Bibliographic Details
Main Authors: Camilo Montero, Nancy Yomayusa, Rodolfo Torres, Jorge Cortes, Carlos Alvarez, Juan Gallo, Guillermo Aldana, Andres Acevedo, Maria Rios, Johana Echeverri, Zuly Yepes, Adriana Silva, Diana Gayon, Jorge Perez, Milciades Ibanez
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:Nefrología (English Edition)
Subjects:
Infeccion por cytomegalovirus
Trasplante renal
Timoglobulina
Basiliximab
Funcion del injerto
Histologia renal
Online Access:http://www.sciencedirect.com/science/article/pii/S2013251422001432

Internet

http://www.sciencedirect.com/science/article/pii/S2013251422001432

Similar Items